Accurate Wealth Management LLC Makes New Investment in iShares U.S. Pharmaceuticals ETF $IHE

Accurate Wealth Management LLC acquired a new stake in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 75,126 shares of the company’s stock, valued at approximately $6,372,000. iShares U.S. Pharmaceuticals ETF makes up approximately 0.8% of Accurate Wealth Management LLC’s investment portfolio, making the stock its 19th biggest holding. Accurate Wealth Management LLC owned 0.67% of iShares U.S. Pharmaceuticals ETF as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently modified their holdings of the business. Wealthcare Advisory Partners LLC increased its stake in iShares U.S. Pharmaceuticals ETF by 4.4% in the 3rd quarter. Wealthcare Advisory Partners LLC now owns 5,115 shares of the company’s stock valued at $371,000 after purchasing an additional 217 shares in the last quarter. Rothschild Investment LLC lifted its stake in iShares U.S. Pharmaceuticals ETF by 116.9% in the 3rd quarter. Rothschild Investment LLC now owns 846 shares of the company’s stock valued at $61,000 after buying an additional 456 shares in the last quarter. JPMorgan Chase & Co. lifted its stake in iShares U.S. Pharmaceuticals ETF by 1.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 112,379 shares of the company’s stock valued at $8,154,000 after buying an additional 1,443 shares in the last quarter. PNC Financial Services Group Inc. grew its holdings in iShares U.S. Pharmaceuticals ETF by 218.0% during the 3rd quarter. PNC Financial Services Group Inc. now owns 4,074 shares of the company’s stock valued at $296,000 after buying an additional 2,793 shares during the last quarter. Finally, Arkansas Financial Group Inc. grew its holdings in iShares U.S. Pharmaceuticals ETF by 3.2% during the 3rd quarter. Arkansas Financial Group Inc. now owns 7,415 shares of the company’s stock valued at $561,000 after buying an additional 230 shares during the last quarter.

iShares U.S. Pharmaceuticals ETF Stock Down 1.7%

Shares of NYSEARCA:IHE opened at $83.79 on Friday. The company has a market capitalization of $938.45 million, a P/E ratio of 17.75 and a beta of 0.54. The stock’s fifty day simple moving average is $88.09 and its 200-day simple moving average is $82.22. iShares U.S. Pharmaceuticals ETF has a 52-week low of $58.97 and a 52-week high of $92.29.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.